kabutan

COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 30%, Dec-Feb Ordinary Profit Increases by 40%

Mon Apr 14, 2025 3:30 pm JST Earnings

3349 COSMOS Pharmaceutical Corporation 【J-GAAP】

Earnings Report

COSMOS Pharmaceutical Corporation <3349> [TSE Prime] announced its financial results after the market closed on April 14th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending May 2025 (June 2024 to February 2025) expanded 33.7 billion yen, an increase 30.3% compared to the same period last year. The progress rate toward the full-year plan of 34.4 billion yen was 98.2%, also surpassing the five-year average of 73.5%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the March to May period (4Q) is expected to significant drop 92.5% from the same period last year to 0.62 billion yen.

In the most recent three-month period, from December to February (3Q), the consolidated ordinary profit increased 40.0% from the same period last year, reaching 11.9 billion yen. The operating profit margin improved from 3.3% in the same period last year to 4.6%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jun - Feb, 2022 606,302 22,167 24,393 16,283 205.6 73.7 Apr 10, 2023 J-GAAP
Jun - Feb, 2023 715,311 23,738 25,914 17,357 219.1 75.6 Apr 12, 2024 J-GAAP
Jun - Feb, 2024 752,268 31,627 33,771 22,343 281.9 98.2 Apr 14, 2025 J-GAAP
YoY +5.2% +33.2% +30.3% +28.7% +28.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec - May, 2023 488,559 15,665 16,953 12,867 162.4 30 Jul 12, 2024 J-GAAP
Dec - May, 2024 Guidance 531,064 11,256 12,623 10,072 127.1 32.50 Jan 10, 2025 J-GAAP
YoY +8.7% -28.1% -25.5% -21.7% -21.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2023 827,697 30,128 33,086 23,797 300.5 50 Jul 10, 2023 J-GAAP
May, 2024 964,989 31,501 34,299 24,454 308.6 60 Jul 12, 2024 J-GAAP
May, 2025 Guidance 1,037,000 31,600 34,400 24,500 309.1 65 Jul 12, 2024 J-GAAP
YoY +7.5% +0.3% +0.3% +0.2% +0.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Dec - Feb, 2023 238,881 7,902 8,568 5,770 72.8 3.3 Apr 12, 2024 J-GAAP
Mar - May, 2024 249,678 7,763 8,385 7,097 89.6 3.1 Jul 12, 2024 J-GAAP
Jun - Aug, 2024 261,841 11,580 12,293 8,143 102.7 4.4 Oct 11, 2024 J-GAAP
Sep - Nov, 2024 244,095 8,764 9,484 6,285 79.3 3.6 Jan 10, 2025 J-GAAP
Dec - Feb, 2024 246,332 11,283 11,994 7,915 99.9 4.6 Apr 14, 2025 J-GAAP
YoY +3.1% +42.8% +40.0% +37.2% +37.1%

Related Articles